Incyte sec
WebApr 9, 2024 · Dupont Capital Management Corp lifted its position in shares of Incyte Co. (NASDAQ:INCY - Get Rating) by 215.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission.The institutional investor owned 9,032 shares of the biopharmaceutical company's stock after … WebApr 15, 2024 · International Biotechnology Trust PLC lowered its stake in Incyte Co. (NASDAQ:INCY - Get Rating) by 20.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 229,000 shares of the biopharmaceutical company's stock after selling 60,000 shares during the period. Incyt
Incyte sec
Did you know?
WebAfter news of Pfizer's Medivation buyout broke, Incyte's shares jumped. 5 years after Pfizer buyout, SEC charges Medivation's former deal-making lead with insider trading Fierce Pharma Fierce Pharma WebAug 17, 2024 · In a complaint filed in federal court, the agency alleged Matthew Panuwat used confidential information he acquired at Medivation to purchase stock options in Incyte ( INCY) “within minutes” of...
WebApr 13, 2024 · New York State Teachers Retirement System lessened its holdings in shares of Incyte Co. (NASDAQ:INCY - Get Rating) by 6.4% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 226,077 shares of the biopharmaceutical company's stock after selling 15,367 shares WebApr 6, 2024 · INCY Incyte CorporationSEC Filings. $75.51 1.73 ( +2.34%) 4:00 PM 04/06/23. NASDAQ $USD Post-Market: $76.42 +0.91 (+1.21%) 7:34 PM. Summary. Ratings. …
WebApr 12, 2024 · Ballentine Partners LLC acquired a new position in shares of Incyte Co. ( NASDAQ:INCY - Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 2,609 shares of the biopharmaceutical company's stock, valued at approximately $210,000. 3 S&P 500 … WebApr 15, 2024 · Sumitomo Mitsui Trust Holdings Inc. owned approximately 0.34% of Incyte worth $59,867,000 as of its most recent filing with the Securities and Exchange …
WebFeb 8, 2024 · The SEC alleges that Panuwat knew, or was reckless in not knowing, that the information about Medivation’s imminent acquisition at a significant premium was …
WebMar 31, 2024 · (ii) Commercialize Incyte Combination Compounds as a component of an Incyte Non-Fixed Dose JAK Combination Regimen (i.e. label license) in the Novartis JAK … easter writing activities eyfsWebJan 27, 2024 · According to the SEC, within minutes of learning that information, Panuwat purchased 578 call options for shares of Incyte, another mid-cap biopharmaceutical … cullied meaningWebFeb 23, 2011 · Incyte Corp (INCY) SEC Filing 10-K Annual report for the fiscal year ending Friday, December 31, 2010. Home. SEC Filings. Incyte Corp (INCY) 10-K Annual Report Wed Feb 23 2011; ... Incyte Corporation (Nasdaq:INCY) today reported fourth quarter and full year 2010 financial results, provided 2011 key objectives, and announced its 2011 financial ... cull house 11782WebMar 3, 2024 · MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ: MOR) and Incyte Corporation (NASDAQ: INCY) announced today that their joint collaboration and license agreement for the further development and global commercialization of MorphoSys' investigational compound tafasitamab (MOR208) has … easter writing activitiescull horsesWebIncyte prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Incyte investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information ... cull house hoursWebIncyte Corp. Watch list Create INCY Alert After Hours Last Updated: Dec 5, 2024 7:45 p.m. EST Delayed quote $ 84.70 0.62 0.74% After Hours Volume: 343.62K Advanced Charting $ … cull house menu